Arcus Biosciences Inc (RCUS)
Working capital turnover
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (ttm) | US$ in thousands | 258,000 | 263,000 | 247,000 | 237,000 | 117,000 | 119,355 | 121,236 | 118,995 | 112,000 | 433,144 | 408,724 | 399,137 | 398,304 | 53,292 | 108,361 | 92,939 | 77,517 | 77,780 | 15,000 | 15,000 |
| Total current assets | US$ in thousands | 1,016,000 | 1,127,000 | 1,022,000 | 1,064,000 | 831,000 | 882,000 | 986,000 | 1,015,000 | 1,067,000 | 1,101,120 | 1,227,480 | 1,264,230 | 1,262,000 | 545,288 | 745,954 | 841,870 | 735,815 | 797,199 | 471,599 | 166,217 |
| Total current liabilities | US$ in thousands | 226,000 | 215,000 | 199,000 | 204,000 | 184,000 | 200,000 | 180,000 | 179,000 | 193,000 | 177,176 | 164,024 | 161,254 | 166,000 | 142,866 | 130,370 | 132,055 | 121,669 | 162,871 | 40,025 | 21,004 |
| Working capital turnover | 0.33 | 0.29 | 0.30 | 0.28 | 0.18 | 0.18 | 0.15 | 0.14 | 0.13 | 0.47 | 0.38 | 0.36 | 0.36 | 0.13 | 0.18 | 0.13 | 0.13 | 0.12 | 0.03 | 0.10 |
December 31, 2024 calculation
Working capital turnover = Revenue (ttm) ÷ (Total current assets – Total current liabilities)
= $258,000K ÷ ($1,016,000K – $226,000K)
= 0.33
The working capital turnover ratio for Arcus Biosciences Inc has fluctuated over the past few years. It stood at 0.10 on March 31, 2020, decreased to 0.03 on June 30, 2020, and then showed an increasing trend, reaching 0.38 on June 30, 2022. It further increased to 0.47 on September 30, 2022, before decreasing slightly to 0.13 on December 31, 2022. The ratio remained relatively stable around 0.13-0.18 until March 31, 2023. Subsequently, it increased to 0.33 by December 31, 2024.
The fluctuations in the working capital turnover ratio indicate changes in how efficiently Arcus Biosciences Inc is managing its working capital to generate revenue. A higher ratio suggests that the company is effectively utilizing its working capital to support revenue generation and operations. Conversely, a lower ratio may indicate inefficiencies in working capital management. It is essential for the company to monitor this ratio closely to ensure optimal utilization of its working capital resources.
Peer comparison
Dec 31, 2024